Determinants of Metabolic Control in Children With Type 1 Diabetes Mellitus
- Disease/Condition
- Diabetes Mellitus, Type 1
- Drug/Device/Intervention
- Blood and saliva analysis
- Study type
- Observational
- Intervention type
- diagnostic test
- Primary sponsor
- IRCCS Burlo Garofolo
- Location
- Trieste, Italy
- Phase
- N/A
- Start date
- Nov 11, 2021
- End date
- Dec 31, 2024
- Enrollment
- 800 participants
Identification of environmental factors affecting T1DM metabolic control,Identification of genetic factors affecting T1DM metabolic control
A good metabolic control of type 1 diabetes mellitus (T1DM) is crucial to avoid long-term
 complications associated with the disease. Although recent evidences suggest that a good
 metabolic control of T1DM is partly independent of management intensity and could be
 anticipated since onset, factors that influence glycated haemoglobin (HbA1c) patterns remain
 poorly understood and are likely to be genetic.
 
 While significant progress has been made in understanding of the genetic contribution to T1DM
 onset, very few studies have evaluated the role of genetic factors on T1DM metabolic control.
 
 This study aims to create a comprehensive database of genetic and phenotypic data in a cohort
 of children and young adults with T1DM and to evaluate genetic and environmental factors that
 might predict trajectories in glycemic control
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06317454
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06317454 through Pure Global AI's free database. This phase not specified trial is sponsored by IRCCS Burlo Garofolo and is currently Recruiting. The study focuses on Diabetes Mellitus, Type 1. Target enrollment is 800 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.